Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Herpetic Keratitis AfterIntravitreal TriamcinoloneInjection

İntravitrealTriamsinolonEnjeksiyonu Sonrası Gelişen HerpesSimpleks Keratiti

Pages
78–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intravitreal triamcinolone acetonide is used for a broad spectrum of inflamatory, neovascular and edematous retinal diseases.1 Increase in intraocular pressure,cataract formation ,retinal break,retinal detachment,intraocular hemorrhage,infectious or non-infectious endophthalmitis are the reported complications so far.1,2 We report a case of herpetic keratitis that devleoped after intravitreal triamcinolone acetonide injection

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intravitreal triamcinolone acetonide is used for a broad spectrum of inflamatory, neovascular and edematous retinal diseases.1 Increase in intraocular pressure,cataract formation ,retinal break,retinal detachment,intraocular hemorrhage,infectious or non-infectious endophthalmitis are the reported complications so far.1,2 We report a case of herpetic keratitis that devleoped after intravitreal triamcinolone acetonide injection
📊
Key Findings & Data:Intravitreal triamcinolone acetonide is used for a broad spectrum of inflamatory, neovascular and edematous retinal diseases.1 Increase in intraocular pressure,cataract formation ,retinal break,retinal detachment,intraocular hemorrhage,infectious or non-infectious endophthalmitis are the reported complications so far.1,2 We report a case of herpetic keratitis that devleoped after intravitreal triamcinolone acetonide injection
💡
Conclusion & Impact:Intravitreal triamcinolone acetonide is used for a broad spectrum of inflamatory, neovascular and edematous retinal diseases.1 Increase in intraocular pressure,cataract formation ,retinal break,retinal detachment,intraocular hemorrhage,infectious or non-infectious endophthalmitis are the reported complications so far.1,2 We report a case of herpetic keratitis that devleoped after intravitreal triamcinolone acetonide injection
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Intravitreal triamcinolone acetonide is used for a broad spectrum of inflamatory, neovascular and edematous retinal diseases.1 Increase in intraocular pressure,cataract formation ,retinal break,retinal detachment,intraocular hemorrhage,infectious or non-infectious endophthalmitis are the reported complications so far.1,2 We report a case of herpetic keratitis that devleoped after intravitreal triamcinolone acetonide injection

Özet

İntravitreal Triamsinolon Asetonit (IVTA) pek çok intraoküler inflamatuar, neovasküler ve ödematöz hastalıkta uygulanmaktadır.1 Göz içi basıncı artışı, katarakt oluşumu veya ilerlemesi, retinal yırtık , retina dekolmanı , intraoküler kanama , enfeksiyöz ve enfeksiyöz olmayan endoftalmi bildirilen komplikasyonları arasındadır.1,2 Bu çalışmada diyabete bağlı makula ödemi nedeniyle uygulanan intravitreal triamsinolon asetonit (İVTA) enjeksiyonu sonrası herpes simpleks keratiti gelişen bir olgunun tedavi süreci sunulmaktadır

🔖

Cite This Article

KÜÇÜK, E., ABİT, M. S., GÜVEN, D. (2015). Herpetic Keratitis AfterIntravitreal TriamcinoloneInjection. Retina-Vitreus, Cilt: 23 - Sayı: 0, 78–80. https://ajindex.com/articles/308037

References (6)

  1. Cunningham MA. Intravitreal steroids for macular edema: The past, the present, and the future. Surv Ophthalmol 53:139-49.
  2. Fraser-Bell S, Kaines A, Hykin PG. Update on treatments for diabetic macular edema. Current opinion in Ophthalmology 2008;19:185-9.
  3. Shtein RM, Stahl RM, Saxe SJ, et al. Herpes simplex keratitis after ıntravitreal triamcinolone acetonide. Cornea 2007;26:641-2.
  4. Gulkilik G, Demirci G, Ozdamar AM, et al. A Case of herpetic keratitis after ıntravitreal triamcinolone ınjection. Cornea 2007;26:1000-1.
  5. Kaiserman I, Kaiserman N, Nakar S, et al. Herpetic eye disease in dia- betic patients. Ophthalmology 2005;112:2184-8.
  6. Beer PM, Bakri SJ, Singh RJ, et al. Intraocular concentration and phar- macokinetics of triamcinolone acetonide after a single intravitreal injec- tion. Ophthalmology 2003;110:681-6. Jonas BJ. Intraocular Availibility of triamcinolone acetonide after in- travitreal injection. Am J Ophthalmol 2004;137:560-2.